ANAB — AnaptysBio Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Annual balance sheet for AnaptysBio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2017 December 31st	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	248	427	374	394	548
Net Total Receivables	1.6	0.174	0	—	0.876
Prepaid Expenses
Total Current Assets	253	434	378	397	554
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.665	1.45	3.02	2.13	21.8
Long Term Investments
Other Long Term Assets
Total Assets	329	509	435	417	643
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	14.1	21.8	29.5	19.8	16.1
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	21.8	22.6	30.2	19.8	287
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	308	486	405	397	356
Total Liabilities & Shareholders' Equity	329	509	435	417	643
Total Common Shares Outstanding

Discover the metrics influencing AnaptysBio's share price